Scopolamine as an antidepressant

Clinical Neuropharmacology

Volumn 36, Issue 3, 2013, Pages 102-

  Pae, Chi Un ^a,b  

^a The Catholic University of Korea   (South Korea)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARECOLINE; CITALOPRAM; FLUOXETINE; IMIPRAMINE; PIRENZEPINE; SCOPOLAMINE; SERTRALINE; TELENZEPINE; VENLAFAXINE;

ANTIDEPRESSANT ACTIVITY; HAMILTON SCALE; HUMAN; LETTER; MAJOR DEPRESSION; NONHUMAN; PRIORITY JOURNAL; SOCIAL BEHAVIOR; SOCIAL INTERACTION;

ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; HUMANS; SCOPOLAMINE HYDROBROMIDE;

EID: 84878832371     PISSN: 03625664     EISSN: 1537162X     Source Type: Journal    
DOI: 10.1097/WNF.0b013e318290b8c8     Document Type: Letter

References (11)

1. Jaffe RJ, Novakovic V, Peselow ED. Scopolamine as an antidepressant: a systematic review. Clin Neuropharmacol 2013;36(1):24-26.
2. Chau D, Rada PV, Kosloff RA, et al. Cholinergic, M1 receptors in the nucleus accumbens mediate behavioral depression. A possible downstream target for fluoxetine. Ann N Y Acad Sci 1999;877:769-774.
3. Chau DT, Rada P, Kosloff RA, et al. Nucleus accumbens muscarinic receptors in the control of behavioral depression: antidepressant-like effects of local M1 antagonist in the Porsolt swim test. Neuroscience 2001;104(3):791-798.
4. Miyakawa T, Yamada M, Duttaroy A, et al. Hyperactivity and intact hippocampus-dependent learning in mice lacking the M1 muscarinic acetylcholine receptor. J Neurosci 2001;21(14):5239-5250.
5. Tozzi A, de Iure A, Di Filippo M, et al. The distinct role of medium spiny neurons and cholinergic interneurons in the D(2)/A(2)A receptor interaction in the striatum: implications for Parkinson's disease. J Neurosci 2011;31(5):1850-1862.
6. Pratt WE, Kelley AE. Nucleus accumbens acetylcholine regulates appetitive learning and motivation for food via activation of muscarinic receptors. Behav Neurosci 2004;118(4):730-739.
7. Pratt WE, Blackstone K. Nucleus accumbens acetylcholine and food intake: decreased muscarinic tone reduces feeding but not food-seeking. Behav Brain Res 2009;198(1):252-257.
8. Benveniste M, Wilhelm J, Dingledine RJ, et al. Subunit-dependent modulation of kainate receptors by muscarinic acetylcholine receptors. Brain Res 2010;1352:61-69.
9. Chen YW, Rada PV, Butzler BP, et al. Corticotropin-releasing factor in the nucleus accumbens shell induces swim depression, anxiety, and anhedonia along with changes in local dopamine/acetylcholine balance. Neuroscience 2012;206:155-166.
10. Seed B, Mechanic J. Treating psychological conditions using muscarinic receptor M1 antagonists (Patent application number: 20110195952). US Patent application 2007.
11. Khajavi D, Farokhnia M, Modabbernia A, et al. Oral scopolamine augmentation in moderate to severe major depressive disorder: a randomized, double-blind, placebo-controlled study. J Clin Psychiatry 2012;73(11):1428-1433.